FDA
-
-
-
-
-
-
-
A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout
-
-
-
-
-
-
-
Canaccord Reiterates Buy Rating on Compass Pathways (CMPS)
-
-
-
-
-
-
-
Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026
-
-
-
-
-
-
-
Compass Pathways elects Kathleen Tregoning to board of directors
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Compass Pathways (CMPS)
-
-
-
-
-
-
-
TD Cowen on Compass Pathways (CMPS) FDA Grant: 'meaningful positive and expected in light of last Saturday’s Executive Order'
-
-
-
-
-
-
-
Compass Pathways partners with Osmind to prepare clinics for psychedelic care
-
327,796 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

